Geode Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.38M Buy
3,566,813
+453,085
+15% +$938K ﹤0.01% 2534
2025
Q1
$6.85M Buy
3,113,728
+98,401
+3% +$217K ﹤0.01% 2506
2024
Q4
$4.61M Sell
3,015,327
-30,034
-1% -$46K ﹤0.01% 2785
2024
Q3
$6.06M Sell
3,045,361
-66,974
-2% -$133K ﹤0.01% 2660
2024
Q2
$10.9M Buy
3,112,335
+316,216
+11% +$1.11M ﹤0.01% 2273
2024
Q1
$7.75M Buy
2,796,119
+171,445
+7% +$475K ﹤0.01% 2474
2023
Q4
$4.46M Buy
2,624,674
+229,513
+10% +$390K ﹤0.01% 2764
2023
Q3
$2.47M Buy
2,395,161
+340,735
+17% +$351K ﹤0.01% 2998
2023
Q2
$2.38M Buy
2,054,426
+79,472
+4% +$92.2K ﹤0.01% 3055
2023
Q1
$2.98M Buy
1,974,954
+16,512
+0.8% +$24.9K ﹤0.01% 2859
2022
Q4
$4.9M Buy
1,958,442
+132,143
+7% +$330K ﹤0.01% 2678
2022
Q3
$7.71M Buy
1,826,299
+13,665
+0.8% +$57.7K ﹤0.01% 2426
2022
Q2
$5.06M Buy
1,812,634
+168,274
+10% +$469K ﹤0.01% 2694
2022
Q1
$9.41M Sell
1,644,360
-67,248
-4% -$385K ﹤0.01% 2385
2021
Q4
$15.6M Buy
1,711,608
+99,233
+6% +$906K ﹤0.01% 2126
2021
Q3
$17.2M Buy
1,612,375
+22,983
+1% +$246K ﹤0.01% 2060
2021
Q2
$24.7M Buy
1,589,392
+148,247
+10% +$2.3M ﹤0.01% 1829
2021
Q1
$23.4M Buy
1,441,145
+136,474
+10% +$2.21M ﹤0.01% 1775
2020
Q4
$27.6M Buy
1,304,671
+47,381
+4% +$1M ﹤0.01% 1519
2020
Q3
$18.6M Sell
1,257,290
-10,896
-0.9% -$161K ﹤0.01% 1588
2020
Q2
$18.7M Buy
1,268,186
+60,675
+5% +$893K ﹤0.01% 1564
2020
Q1
$14.2M Buy
1,207,511
+75,251
+7% +$883K ﹤0.01% 1518
2019
Q4
$26.6M Buy
1,132,260
+210,035
+23% +$4.94M 0.01% 1366
2019
Q3
$17.1M Buy
922,225
+25,145
+3% +$465K ﹤0.01% 1589
2019
Q2
$16.7M Buy
897,080
+81,852
+10% +$1.52M ﹤0.01% 1606
2019
Q1
$19.9M Buy
815,228
+63,978
+9% +$1.56M 0.01% 1421
2018
Q4
$19.5M Buy
751,250
+26,429
+4% +$686K 0.01% 1297
2018
Q3
$22.9M Buy
724,821
+77,210
+12% +$2.44M 0.01% 1309
2018
Q2
$25.2M Buy
647,611
+171,911
+36% +$6.68M 0.01% 1188
2018
Q1
$13.1M Buy
475,700
+78,244
+20% +$2.16M ﹤0.01% 1566
2017
Q4
$7.19M Buy
397,456
+2,410
+0.6% +$43.6K ﹤0.01% 1981
2017
Q3
$6.38M Buy
395,046
+8,420
+2% +$136K ﹤0.01% 2047
2017
Q2
$5.35M Buy
386,626
+26,986
+8% +$374K ﹤0.01% 2104
2017
Q1
$5.39M Buy
359,640
+95,084
+36% +$1.43M ﹤0.01% 2057
2016
Q4
$3.47M Buy
264,556
+9,518
+4% +$125K ﹤0.01% 2290
2016
Q3
$4.39M Buy
255,038
+36,050
+16% +$621K ﹤0.01% 2049
2016
Q2
$3.95M Buy
218,988
+11,199
+5% +$202K ﹤0.01% 2071
2016
Q1
$3.95K Buy
207,789
+2,908
+1% +$55 ﹤0.01% 2021
2015
Q4
$5.47M Sell
204,881
-6,125
-3% -$163K ﹤0.01% 1808
2015
Q3
$5.15M Buy
211,006
+12,956
+7% +$316K ﹤0.01% 1826
2015
Q2
$6.17M Buy
198,050
+49,270
+33% +$1.54M ﹤0.01% 1758
2015
Q1
$2.16M Buy
148,780
+23,296
+19% +$339K ﹤0.01% 2388
2014
Q4
$1.26M Buy
125,484
+2,017
+2% +$20.3K ﹤0.01% 2704
2014
Q3
$1.03M Buy
123,467
+13,683
+12% +$114K ﹤0.01% 2761
2014
Q2
$1.35M Buy
109,784
+47,541
+76% +$585K ﹤0.01% 2613
2014
Q1
$865K Buy
+62,243
New +$865K ﹤0.01% 2874